University of Verona
UNIVR has 22,000 students and 1,500 staff including lecturers, researchers, and administrative personnel. A forward-thinking institution which continuously seeks to strengthen the link between its courses and the world of work. It ranks 394° as regards Life Sciences and Medicine according to the QS World University Rankings by Subject, 2020.
UNIVR is the leader of WP5, which is the clinical WP. In this role, it will be the coordinator and main implementing center of the TAPE-Obesity trial and the ADOBESIF trial and will assist APHP in supervising the ObGe-SEMA trial. In addition, UNIVR will participate in WP1, contributing to the construction of the catalog of harmonized cohorts, in WP3, providing phenotypes and DNA from families potentially useful for the discovery of new forms of Mendelian obesity, and in WP6, participating in the working groups for the dissemination of results.
Associate Professor, Medical doctor, Paediatrician and PhD with particular interest in genetics, diabetology, endocrinology and clinical nutrition. Good clinical experience in pediatric diabetology and nutrition and good skills as a researcher thanks to an international doctoral formation (international co-tutored fellowship) at the CNRS (Pasteur Institute, Lille, FR) and at the University of Verona (Verona, I). Member of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED) and of the ISPED Obesity Study Group, of the Italian Society of Obesity (SIO) and of the SIO Scientific Committee, of the European Society for Pediatric Endocrinology (ESPE) and of the European Childhood Obesity Group (ECOG). Awarded the ISPED Balducci Prize for research in 2017. Awarded the SIO Best Oral Communication Prize in 2023. Author of 91 scientific publications in international journals (Scopus HI 24 in September/2023)